Discover Great Companies Discover Great Clients
Popularity  1.8万   |   Followers  10   |   Likes  32   |   Feedback  4 Claim this company
Suzhou Industrial Park Jiangsu No.7 Lin Chuang Qian Yan Jiu No.8 Analysis Testing No.9 Generic Drugs No.12 Emergency No.17 Pharmaceutical APIs No.18 Yi Yao Xin Yao No.19 Kang Zhong Liu Yao No.19 APIs No.25 Yuan Yan Yao No.25 Innovative Drugs Products No.27 Xin Yao R&D No.35 Innovative Drugs 科技型中小企业 民营科技企业 省科技型中小企业 省民营科技企业 高新技术企业 省级高新技术企业
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 13年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Suzhou Vigonvita Biopharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #7 in Suzhou Lin Chuang Qian Yan Jiu Company by popularity Ranked #8 in Suzhou Analysis Testing Company by popularity Ranked #9 in Suzhou Generic Drugs Company by popularity
  • Honors: 科技型中小企业 民营科技企业 According to algorithm
  • Salary: 81.1% of positions earn 8-50K, In 2026 vs last yeardecreased by 14%.。Master's salary: ¥40.0K, Doctorate salary: ¥40.0K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 32.8%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 12.1%, "Other (R&D and Technical)": 10.3%。
  • Recruiting: In 2026 vs 2025grew by 32%.
  • Requirement: Education: 本科 leads with 51.7%. Experience: 不限 leads with 62.1%.
  • Region: Distributed across 3 regions, 苏州: 46.6%, 上海: 12.1%, 广州: 10.3%, 北京: 3.4%.

About the Company

Suzhou Vigonvita Biopharmaceutical Co., Ltd. (hereinafter referred to as "Vigonvita") was founded in 2013 and was listed on the Main Board of the Hong Kong Stock Exchange in November 2025 under the stock code 2630.HK.
Vigonvita is an innovation-driven biopharmaceutical company with the mission of improving patients' health and quality of life, dedicated to the development of new drugs in the fields of viral infections, neuropsychiatry, and reproductive health. Vigonvita has built a comprehensive system covering the entire industry chain and full internal control, from innovative drug lead discovery to druggability evaluation, preclinical research, clinical research, manufacturing, and commercialization, rapidly and efficiently translating lead compounds from laboratory research into clinical applications.
Vigonvita has developed a highly competitive and diversified pipeline of innovative drug products, among which two innovative drugs are in the commercialization stage, five drug candidates are in the clinical trial stage, and three candidate compounds are in the preclinical research stage. VV116 is an orally administered nucleoside RNA-dependent RNA polymerase inhibitor with broad-spectrum antiviral potential; its tablet has been approved for marketing in China (trade name: Mindeweiy®) and Uzbekistan (trade name: Mindvy®) for the indication of COVID-19 infection; a Phase II clinical trial of its dry suspension for respiratory syncytial virus (RSV) infection in infants and young children has been completed, with positive clinical trial results, based on which the deutetrabenazine hydrobromide (VV116) dry suspension has been included in the Breakthrough Therapy Designation list by the Center for Drug Evaluation (CDE) of the National Medical Products Administration. TPN171 is a highly active and highly selective PDE5 inhibitor with a novel chemical structure; its tablet has been approved for marketing in China (trade name: Angweida®) and Uzbekistan (trade name: Onvita®) for the indication of erectile dysfunction.
Vigonvita will continue to uphold the concept of innovation-driven development, deeply cultivate the fields of viral infections, neuropsychiatry, and reproductive health, help patients relieve pain, and make contributions to society.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (10 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 131%
  • 2024: Down 75%
  • 2023: Up 97%
  • 2022: Down 65%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Interns 1
Note: How fast is hiring at Suzhou Vigonvita Biopharmaceutical Co., Ltd. growing? 2026: 49 openings (up 32%), 2025: 37 openings (up 131%), 2024: 16 openings (down 75%), 2023: 63 openings (up 97%), 2022: 32 openings (down 65%), 2021: 91 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Suzhou Vigonvita Biopharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2026: 1 openings (up 32%), 2024: 2 openings (down 75%), 2023: 10 openings (up 97%), 2022: 8 openings (down 65%).

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou Vigonvita Biopharmaceutical Co., Ltd.? Based on an analysis of 's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 32.8%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 12.1%, "Other (R&D and Technical)": 10.3%, "Scientific Research": 10.3%, "Computer/Network/Technology": 10.3%. For reference only.

— What Are the Salaries Like? (58 records)

Manage
salary range: 2K - 50K, 81.1% of roles pay ¥8-50K
Note: salary statistics are based on 58 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou Vigonvita Biopharmaceutical Co., Ltd.?81.1% of positions earn 8-50K, Undergraduate salary: ¥。Suzhou salary ranking top 25,Sales average salary ¥20.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Suzhou Vigonvita Biopharmaceutical Co., Ltd.? We provide: Key Account Manager, 省区经理, Retail, Marketing, 推广, Researcher, Operations, Channel Manager, Administrative Specialist, Chemistry, Finance Specialist, Sales, Product Manager, Human Resources, Accountant, 出纳, 医学经理, 国际注册, General Ledger Accountant, Investor Relations. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Job Category

  • Sales
    39.7% of total 39.7%
  • Medical & Health/Beauty & Healthcare
    32.8% of total 32.8%
  • Business Management
    32.8% of total 32.8%
  • Customer Service
    17.2% of total 17.2%

Education

  • 本科
    51.7% of total 51.7%
  • 大专
    36.2% of total 36.2%
  • 硕士
    10.3% of total 10.3%
  • 博士
    1.7% of total 1.7%

Experience

  • 不限
    62.1% of total 62.1%
  • 3-5年
    20.7% of total 20.7%
  • 1-3年
    13.8% of total 13.8%
  • 5-10年
    3.4% of total 3.4%
View Detailed Analysis

What does Suzhou Vigonvita Biopharmaceutical Co., Ltd. require? Who is Suzhou Vigonvita Biopharmaceutical Co., Ltd. hiring? recruitment: Sales占比最多占39.7%,其次是Medical & Health/Beauty & Healthcare占32.8%. What education can get in at ? 本科占比最多占51.7%,其次是大专占36.2%. High education required at ? 硕士占10.3%,博士占1.7%. Work experience required at ? 不限占比最多占62.1%,其次是3-5年占20.7%. Where are the job locations at ? 苏州占比最多占46.6%,其次是上海占12.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 15,000万(元)
Legal Representative: 田广辉
Date Established:
Credit Code: 91320594061826009W
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区裕新路108号A栋8楼(该地址不得从事零售)

Partners & Suppliers

双方合作开发口服核苷类抗新冠病毒药物VV116,君实生物负责全球商业化,旺山旺水负责原料药生产和技术支持。 Source
合作客户 抗病毒药物研发
双方合作进行抗病毒活性评价与药效学研究。 Source
供应商 抗病毒药物研发
双方合作研发抗新冠病毒药物,上海药物所负责药物设计与先导化合物优化。 Source
供应商 抗病毒药物研发

People who follow this company also follow

Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
电子商务 生产 毛衫 套头毛衣
“Primarily engaged in the R&D, production, and sales of low-voltage ele”
制造 研发 定制 汽车质量
“Focusing on providing comprehensive energy services and solutions to p”
加热膜 薄膜 碳纳米 纳米材料
汽车产业链 制造 本地化 品牌经销
车床 铣床 过滤器 截止阀
工程设计 环境工程 废气治理 环保工程
仪器/仪表 量具 机电 机床
肉制品 乳化剂 食品 代理分销
冷凝器 蒸发器 饮水机 点焊机
磷肥 磷复肥 磷酸一铵 硝基肥
变压器 电力设备 开关柜 变电站
紧固件 螺钉 螺丝 铝件

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Industrial Park”公司名录 苏州“制药/药业”公司名录 苏州“药物研发”公司名录 苏州“生物医药”公司名录 苏州“临床前研究”公司名录 苏州“抗肿瘤药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates